Adam Scott Levy, CFO and Secretary at Mineralys Therapeutics, Inc. (MLYS), sold 21,516 shares at $41.90 ($904K) on 2025-10-13, disclosed to the SEC on 2025-10-15.
Scheduled sale ($904k) by CFO and Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.90 | 7,366 | $309K | 34.1% |
| 2 | $41.90 | 7,366 | $309K | 34.1% |
| 3 | $42.26 | 3,392 | $143K | 15.9% |
| 4 | $42.26 | 3,392 | $143K | 15.9% |
| Total | $42.01 avg | 21,516 | $904K | 100% |
| Filing → |
| MLYS | SELL | 2025-07-30 | $1.4M | — | Filing → |
| MLYS | SELL | 2025-07-15 | $311K | — | Filing → |
| MLYS | SELL | 2025-04-15 | $259K | — | Filing → |